Clinical Irreversible Electroporation Equipment - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Medical Devices & Consumables > Clinical Irreversible Electroporation Equipment - Global Top Players Market Share and Ranking 2025

Clinical Irreversible Electroporation Equipment - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-01
Report Id: 2858711
Industry: Medical Devices & Consumables
Report Page: 107
Chart: 108

PDF Download

Publication Date: 2025-12-01
Report Id: 2858711
Industry: Medical Devices & Consumables
Report Page: 107
Chart: 108

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Clinical Irreversible Electroporation Equipment Definition
1.2 Global Clinical Irreversible Electroporation Equipment Market Size and Forecast
1.2.1 By Consumption Value, Global Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.2.3 Global Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031
1.3 China Clinical Irreversible Electroporation Equipment Market Size and Forecast
1.3.1 By Consumption Value, China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.3.2 By Sales Quantity, China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
1.3.3 China Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031
1.4 Share of China Clinical Irreversible Electroporation Equipment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Clinical Irreversible Electroporation Equipment Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Clinical Irreversible Electroporation Equipment Market Share in Global, 2020-2031
1.4.3 Clinical Irreversible Electroporation Equipment Market Size: China VS Global, 2020-2031
1.5 Clinical Irreversible Electroporation Equipment Market Dynamics
1.5.1 Clinical Irreversible Electroporation Equipment Market Drivers
1.5.2 Clinical Irreversible Electroporation Equipment Market Restraints
1.5.3 Clinical Irreversible Electroporation Equipment Industry Trends
1.5.4 Clinical Irreversible Electroporation Equipment Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Clinical Irreversible Electroporation Equipment, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Clinical Irreversible Electroporation Equipment, Global Market Share by Company, 2020-2025
2.3 Clinical Irreversible Electroporation Equipment Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Clinical Irreversible Electroporation Equipment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Clinical Irreversible Electroporation Equipment Concentration Ratio
2.6 Global Clinical Irreversible Electroporation Equipment Mergers & Acquisitions, Expansion Plans
2.7 Global Clinical Irreversible Electroporation Equipment Manufacturers Product Type
2.8 Head Office and Clinical Irreversible Electroporation Equipment Production Site of Key Manufacturer
2.9 Clinical Irreversible Electroporation Equipment Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Clinical Irreversible Electroporation Equipment, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Clinical Irreversible Electroporation Equipment, China Market Share by Company, 2020-2025
3.3 China Clinical Irreversible Electroporation Equipment Clinical Irreversible Electroporation Equipment Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Clinical Irreversible Electroporation Equipment Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Clinical Irreversible Electroporation Equipment Capacity by Region
4.3 Global Clinical Irreversible Electroporation Equipment Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Clinical Irreversible Electroporation Equipment Production by Region, 2020-2031
4.5 Global Clinical Irreversible Electroporation Equipment Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Clinical Irreversible Electroporation Equipment Industry Chain
5.2 Clinical Irreversible Electroporation Equipment Upstream Analysis
5.2.1 Clinical Irreversible Electroporation Equipment Core Raw Materials
5.2.2 Main Manufacturers of Clinical Irreversible Electroporation Equipment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Clinical Irreversible Electroporation Equipment Production Mode
5.6 Clinical Irreversible Electroporation Equipment Procurement Model
5.7 Clinical Irreversible Electroporation Equipment Industry Sales Model and Sales Channels
5.7.1 Clinical Irreversible Electroporation Equipment Sales Model
5.7.2 Clinical Irreversible Electroporation Equipment Typical Distributors

6 Sights by Type
6.1 Clinical Irreversible Electroporation Equipment Classification by Type
6.1.1 Pulse Power Generator
6.1.2 Electrode Probe
6.2 by Type, Global Clinical Irreversible Electroporation Equipment Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
6.4 by Type, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
6.5 by Type, Global Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031

7 Sights by Device Grade
7.1 Clinical Irreversible Electroporation Equipment Classification by Device Grade
7.1.1 Microsecond Level
7.1.2 Nanosecond Level
7.2 by Device Grade, Global Clinical Irreversible Electroporation Equipment Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Device Grade, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
7.4 by Device Grade, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
7.5 by Device Grade, Global Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031

8 Sights by Tumor Types
8.1 Clinical Irreversible Electroporation Equipment Classification by Tumor Types
8.1.1 Pancreatic Cancer
8.1.2 Prostate Cancer
8.1.3 Liver Cancer
8.1.4 Other
8.2 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
8.4 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
8.5 by Tumor Types, Global Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031

9 Sights by Form Factor
9.1 Clinical Irreversible Electroporation Equipment Classification by Form Factor
9.1.1 Mobile
9.1.2 Trolley-based
9.2 by Form Factor, Global Clinical Irreversible Electroporation Equipment Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Form Factor, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
9.4 by Form Factor, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
9.5 by Form Factor, Global Clinical Irreversible Electroporation Equipment Average Selling Price (ASP), 2020-2031

10 Sights by Application
10.1 Clinical Irreversible Electroporation Equipment Segment by Application
10.1.1 Hospitals
10.1.2 Clinics
10.2 by Application, Global Clinical Irreversible Electroporation Equipment Consumption Value & CAGR, 2020 VS 2024 VS 2031
10.3 by Application, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
10.4 by Application, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
10.5 by Application, Global Clinical Irreversible Electroporation Equipment Price, 2020-2031

11 Sales Sights by Region
11.1 By Region, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020 VS 2024 VS 2031
11.2 By Region, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
11.3 By Region, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
11.4 North America
11.4.1 North America Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.4.2 By Country, North America Clinical Irreversible Electroporation Equipment Market Size Market Share
11.5 Europe
11.5.1 Europe Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.5.2 By Country, Europe Clinical Irreversible Electroporation Equipment Market Size Market Share
11.6 Asia Pacific
11.6.1 Asia Pacific Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.6.2 By Country/Region, Asia Pacific Clinical Irreversible Electroporation Equipment Market Size Market Share
11.7 South America
11.7.1 South America Clinical Irreversible Electroporation Equipment Market Size & Forecasts, 2020-2031
11.7.2 By Country, South America Clinical Irreversible Electroporation Equipment Market Size Market Share
11.8 Middle East & Africa

12 Sales Sights by Country Level
12.1 By Country, Global Clinical Irreversible Electroporation Equipment Market Size & CAGR, 2020 VS 2024 VS 2031
12.2 By Country, Global Clinical Irreversible Electroporation Equipment Consumption Value, 2020-2031
12.3 By Country, Global Clinical Irreversible Electroporation Equipment Sales Quantity, 2020-2031
12.4 United States
12.4.1 United States Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.4.2 by Type, United States Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.4.3 by Application, United States Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.5 Europe
12.5.1 Europe Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.5.2 by Type, Europe Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.5.3 by Application, Europe Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.6 China
12.6.1 China Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.6.2 by Type, China Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.6.3 by Application, China Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.7 Japan
12.7.1 Japan Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.7.2 by Type, Japan Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.7.3 by Application, Japan Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.8 South Korea
12.8.1 South Korea Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.8.2 by Type, South Korea Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.8.3 by Application, South Korea Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.9 Southeast Asia
12.9.1 Southeast Asia Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.9.2 by Type, Southeast Asia Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.9.3 by Application, Southeast Asia Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.10 India
12.10.1 India Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.10.2 by Type, India Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.10.3 by Application, India Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.11 Middle East & Africa
12.11.1 Middle East & Africa Clinical Irreversible Electroporation Equipment Market Size, 2020-2031
12.11.2 by Type, Middle East & Africa Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031
12.11.3 by Application, Middle East & Africa Clinical Irreversible Electroporation Equipment Sales Quantity Market Share, 2024 VS 2031

13 Manufacturers Profile
13.1 AngioDynamics
13.1.1 AngioDynamics Company Information, Head Office, Market Area, and Industry Position
13.1.2 AngioDynamics Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.1.3 AngioDynamics Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.1.4 AngioDynamics Company Profile and Main Business
13.1.5 AngioDynamics Recent Developments
13.2 IGEA
13.2.1 IGEA Company Information, Head Office, Market Area, and Industry Position
13.2.2 IGEA Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.2.3 IGEA Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.2.4 IGEA Company Profile and Main Business
13.2.5 IGEA Recent Developments
13.3 Surgnova
13.3.1 Surgnova Company Information, Head Office, Market Area, and Industry Position
13.3.2 Surgnova Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.3.3 Surgnova Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.3.4 Surgnova Company Profile and Main Business
13.3.5 Surgnova Recent Developments
13.4 Alpmed
13.4.1 Alpmed Company Information, Head Office, Market Area, and Industry Position
13.4.2 Alpmed Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.4.3 Alpmed Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.4.4 Alpmed Company Profile and Main Business
13.4.5 Alpmed Recent Developments
13.5 Shanghai Nortion Medical Technology
13.5.1 Shanghai Nortion Medical Technology Company Information, Head Office, Market Area, and Industry Position
13.5.2 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.5.3 Shanghai Nortion Medical Technology Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.5.4 Shanghai Nortion Medical Technology Company Profile and Main Business
13.5.5 Shanghai Nortion Medical Technology Recent Developments
13.6 Hangzhou Ready Biological Technology
13.6.1 Hangzhou Ready Biological Technology Company Information, Head Office, Market Area, and Industry Position
13.6.2 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Models, Specifications, and Application
13.6.3 Hangzhou Ready Biological Technology Clinical Irreversible Electroporation Equipment Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
13.6.4 Hangzhou Ready Biological Technology Company Profile and Main Business
13.6.5 Hangzhou Ready Biological Technology Recent Developments

14 Conclusion

15 Appendix
15.1 Research Methodology
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Market Estimation Model
15.4 Disclaimer

According to YH Research, the global market for Clinical Irreversible Electroporation Equipment should grow from US$ 79.64 million in 2024 to US$ 116 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Clinical Irreversible Electroporation Equipment

According to YH Research, the global market for Clinical Irreversible Electroporation Equipment should grow from US$ 79.64 million in 2024 to US$ 116 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Clinical Irreversible Electroporation (IRE) equipment is a high-end minimally invasive therapeutic system that delivers non-thermal tumor ablation through steep pulsed electric fields. By placing multiple needle electrodes around the lesion and delivering high-voltage short pulses, the system induces permanent nanopores in cell membranes and triggers apoptosis, achieving precise ablation while preserving the structural integrity of surrounding tissues. A typical system integrates a high-voltage pulse generator, pulse-modulation unit, multi-channel electrode interface, disposable or reusable electrode sets, imaging-guided navigation modules, and workflow-oriented surgical software. Key upstream components include high-voltage electronic modules, medical-grade alloy electrodes, insulation-coating consumables, surgical-grade metallic materials, and imaging-based localization and control software. Downstream users include oncology hospitals, interventional departments of general hospitals, cancer centers, ambulatory surgery centers, and research institutions, with applications in solid-tumor ablation, electrophysiological interventions, minimally invasive dermatological procedures, and gene/cell-level experimental studies. In 2024, global production capacity is about 400 units, with approximately 223 units sold, an average selling price of USD 336,000 per system, and a gross margin of 40%–50%. Supported by the rapid maturation of non-thermal electric-field ablation technologies and rising demand for treating tumors in challenging anatomical locations, the market continues to expand steadily.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Clinical Irreversible Electroporation Equipment market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Clinical Irreversible Electroporation Equipment market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Hospitals grew percent to account for percent of the total market sales, and Clinics grew percent.

This report studies and analyses global Clinical Irreversible Electroporation Equipment status and future trends, helps the client to determine the Clinical Irreversible Electroporation Equipment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Clinical Irreversible Electroporation Equipment, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Clinical Irreversible Electroporation Equipment market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (Units)
(2) Global Clinical Irreversible Electroporation Equipment sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Units)
(3) China Clinical Irreversible Electroporation Equipment sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (Units)
(4) Global Clinical Irreversible Electroporation Equipment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Clinical Irreversible Electroporation Equipment key producing regions, capacity, production, and year over year growth
(6) Clinical Irreversible Electroporation Equipment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    AngioDynamics
    IGEA
    Surgnova
    Alpmed
    Shanghai Nortion Medical Technology
    Hangzhou Ready Biological Technology

Market segment by Type, covers
    Pulse Power Generator
    Electrode Probe

Market segment by Device Grade, covers
    Microsecond Level
    Nanosecond Level

Market segment by Tumor Types, covers
    Pancreatic Cancer
    Prostate Cancer
    Liver Cancer
    Other

Market segment by Form Factor, covers
    Mobile
    Trolley-based

Market segment by Application, can be divided into
    Hospitals
    Clinics

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Clinical Irreversible Electroporation Equipment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Clinical Irreversible Electroporation Equipment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Clinical Irreversible Electroporation Equipment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Clinical Irreversible Electroporation Equipment, percent & CAGR, 2020-2031
Chapter 5: Clinical Irreversible Electroporation Equipment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.